乳がん治療のためのサラカ・インディカの持続的および標的の配送のための葉酸機能化されたコアシェルナノキャリアシステム
Youssra Ragheb1,2, Sarah Yahia2, Rabab M El Sherif1
1Faculty of Postgraduate Studies for Nanotechnology, Cairo University, Sheikh Zayed City, Giza, Egypt.
Drug development and industrial pharmacy
|February 13, 2026
まとめ
この研究では,サラカ・インディカの抽出物を用いた標的乳がん治療のための新しいナノ粒子を開発しました. この新しいシステムは,薬物の投与を向上させ,マウスの腫瘍の量を大幅に減少させます.
科学分野:
- バイオメディカルエンジニアリング
- ナノテクノロジー ナノテクノロジー
- 薬理学 薬理学とは
背景:
- ターゲティングセラピーは,正常な細胞に対する化学療法による悪影響を最小限に抑えます.
- 治療薬を癌組織に特異的に向けることは,効果的な治療に不可欠です.
研究 の 目的:
- 乳がん (BC) の二重標的と効率的な治療のための新しいナノキャリアシステムを開発する.
- プルーロン酸,ヒアルウロン酸ナトリウム,および葉酸結合キトソーンを用いて,シナージスティックなナノキャリアを作成する.
主な方法:
- コア・シェルナノ粒子 (NP) はプルーロン酸 (PL),ヒアルウロン酸ナトリウム (SH),および葉酸結合キトーサン (CS-FA) を使用して準備されました.
- これらのNPには,抗がん剤*サラカ・インディカ* (SI) 抽出物が詰め込まれていました.
- 合成されたCS-FAはSHと結合してNP殻を形成し,SI負荷のPLナノミセルを封じ込めました.
主要な成果:
- 開発されたコアシェルSI負荷NP (SINP) は,安定したシェル,サイズ224nm,SI負荷47.3%を示した.
- インビトロ試験では,20日間の持続的なSI放出と,フリーSIと比較してMCF-7 BC細胞に対する強化された細胞毒性が示されました.
- 光顕微鏡では,葉酸受容体媒介性エンドサイトーシスによるMCF7細胞による細胞吸収の強化を示し,SINPはマウスの腫瘍量を有意に減少させた.
結論:
- 開発されたSINPは,SI.のための有望な標的型ナノ配信システムを表しています.
- このシステムは,標的型葉酸受容体経路を通じてSIの抗がん効率を高めることで,拡張された乳がん治療を提供します.
キーワード:
アクティブ・ターゲティング アクティブ・ターゲティング乳がん 乳がんは乳がんです.キトーサン・葉酸キトーサン・葉酸エリヒ・アシテスはアシテスです.MCF-7 セルについてサラカ・インディカ サラカ・インディカさらに関連する動画
関連する概念動画
01:43Sustainable Development
15.2K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.2K
02:10The Nucleosome Core Particle
14.6K
Nucleosomes are the DNA-histone complex, where the DNA strand is wound around the histone core. The histone core is an octamer containing two copies of H2A, H2B, H3, and H4 histone proteins.
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
14.6K
01:12The Nucleosome Core Particle
2.4K
Nucleosomes are the DNA-histone complex, where the DNA strand is wound around the histone core. The histone core is an octamer containing two copies of H2A, H2B, H3, and H4 histone proteins.
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their primary aim is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. On the other hand, they must allow polymerase enzymes to access histone-bound DNA during...
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their primary aim is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. On the other hand, they must allow polymerase enzymes to access histone-bound DNA during...
2.4K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
4
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
4